SHL Telemedicine (OTC: SHMLF) CFO reports stock option holdings

Rhea-AI Filing Summary

SHL Telemedicine Ltd CFO Lior Haalman has filed an initial Form 3 reporting direct holdings of stock options linked to the company’s ordinary shares. The filing lists several option positions, each referencing 40,000 underlying ordinary shares, with exercise prices of CHF 3.2500 or CHF 2.7500.

These options become exercisable on different dates between February 13, 2026 and February 13, 2029, and each position carries an expiration date of February 13, 2031. A footnote clarifies that all exercise prices are denominated in Swiss francs (CHF).

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Haalman Lior

(Last) (First) (Middle)

TZUR 2

(Street)

RAMAT GAN 5291115

(City) (State) (Zip)

ISRAEL

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
SHL TELEMEDICINE LTD [ SHLT ]

3a. Foreign Trading Symbol
[SHLTN]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option	02/13/2026	02/13/2031	Ordinary Shares	40,000	$3.25(1)	D
Option	02/13/2026	02/13/2031	Ordinary Shares	40,000	$2.75(1)	D
Option	02/13/2027	02/13/2031	Ordinary Shares	40,000	$3.25(1)	D
Option	02/13/2027	02/13/2031	Ordinary Shares	40,000	$2.75(1)	D
Option	02/13/2028	02/13/2031	Ordinary Shares	40,000	$3.25(1)	D
Option	02/13/2028	02/13/2031	Ordinary Shares	40,000	$2.75(1)	D
Option	02/13/2029	02/13/2031	Ordinary Shares	40,000	$3.25(1)	D
Option	02/13/2029	02/13/2031	Ordinary Shares	40,000	$2.75(1)	D

Explanation of Responses:

1. The exercise price is in CHF.

Remarks:

This Form 3 is filed pursuant to the Holding Foreign Insiders Accountable Act (HFIAA), which extends Section 16(a) reporting obligations to directors and officers of Foreign Private Issuers effective March 18, 2026.

	/s/ Lior Haalman	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does SHL Telemedicine (SHMLF) CFO Lior Haalman report on this Form 3?

CFO Lior Haalman reports initial holdings of stock options linked to SHL Telemedicine ordinary shares. The filing lists several option positions, each tied to 40,000 underlying shares, with specific exercise prices and future exercise and expiration dates.

What are the exercise prices of the SHL Telemedicine CFO’s reported options?

The reported stock options carry exercise prices of CHF 3.2500 and CHF 2.7500. A footnote explains that these exercise prices are denominated in Swiss francs, giving investors clarity on the currency basis for any future exercises.

When can the SHL Telemedicine CFO’s reported options be exercised?

The options disclosed become exercisable on different dates between February 13, 2026 and February 13, 2029. This staggered schedule indicates multiple future exercise windows before the options ultimately reach their stated expiration date in 2031.

When do the SHL Telemedicine CFO’s reported stock options expire?

Each of the reported option positions carries an expiration date of February 13, 2031. After this date, any unexercised options would lapse, so the exercisability window runs from the respective exercise dates through this common 2031 expiration.

How many underlying shares are linked to each SHL Telemedicine option position reported?

Each option entry in the filing references 40,000 underlying ordinary shares of SHL Telemedicine. This figure describes the number of ordinary shares that could be acquired upon exercise of that specific option position, subject to the terms and timing disclosed.

Is the SHL Telemedicine CFO’s Form 3 a buy or sell transaction?

The Form 3 reports holdings of derivative securities rather than new buy or sell transactions. The entries are classified as option holdings with unknown transaction codes, focusing on existing positions, exercise prices, and future exercisability and expiration dates.